Renal Anhydramnios Fetal Therapy

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

March 10, 2025

Study Completion Date

February 28, 2030

Conditions
AnhydramniosPotter SyndromeLung HypoplasiaMulticystic Dysplastic KidneyMulticystic Renal Dysplasia, BilateralLower Urinary Tract Obstructive SyndromeFetal Renal Anomaly
Interventions
PROCEDURE

Serial amnioinfusions with isotonic fluid

Amnioinfusions will be performed by an expert in fetal procedures with a 20 or 22 gauge needle using sterile technique and ultrasound guidance. Local anesthetic will be employed. The fluid will consist of warmed isotonic fluid. Infusions may take up to 1 hour.

DEVICE

Spinal needle

A 20 or 22 gauge spinal needle will be used with sterile technique to access the uterus under ultrasound guidance and to infuse isotonic fluid.

DRUG

Isotonic fluid

Isotonic fluids, including normal saline or lactated ringers solution, will be infused into the uterus through a spinal needle under ultrasound guidance using sterile technique. This fluid will act as replacement amniotic fluid.

Trial Locations (9)

10032

Columbia University, New York

19104

Children's Hospital of Philadelphia, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

55902

Mayo Clinic, Rochester

77030

University of Texas Health Science Center at Houston, Houston

80045

University of Colorado Denver, Aurora

90033

University of Southern California/Children's Hospital of Los Angeles/Huntington Hospital, Los Angeles

94158

University of California San Francisco, San Francisco

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Johns Hopkins University

OTHER